Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 5, 2016, Pages 862-867

  Fitzhugh, David J ^a   Bernstein, David I ^b  

^a University of Chapel Hill   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EPINEPHRINE; BRONCHODILATING AGENT;

ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ARTICLE; ASTHMA; CLINICAL OBSERVATION; CLINICAL PRACTICE; DRUG HYPERSENSITIVITY; EPINEPHRINE AUTOINJECTOR; EVIDENCE BASED MEDICINE; HUMAN; INSECT STING; PATIENT SELECTION; PRESCRIPTION; RISK BENEFIT ANALYSIS; SUBCUTANEOUS IMMUNOTHERAPY; DESENSITIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANAPHYLAXIS; BRONCHODILATOR AGENTS; DESENSITIZATION, IMMUNOLOGIC; EPINEPHRINE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; PRACTICE PATTERNS, PHYSICIANS';

EID: 84969285268     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.04.007     Document Type: Article

References (20)

1. 1 Calderon, M., Cardona, V., Demoly, P., EAACI 100 Years of Immunotherapy Experts Panel. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions. Allergy 67 (2012), 462–476.
2. 2 Amin, H.S., Liss, G.M., Bernstein, D.I., Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 117 (2006), 169–175.
3. 3 Lockey, R.F., Benedict, L.M., Turkeltaub, P.C., Bukantz, S.C., Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79 (1987), 660–677.
4. 4 Reid, M.J., Lockey, R.F., Turkeltaub, P.C., Platts-Mills, T.A., Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 92 (1993), 6–15.
5. 5 Bernstein, D.I., Wanner, M., Borish, L., Liss, G.M., Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 113 (2004), 1129–1136.
6. 6 Epstein, T.G., Liss, G.M., Murphy-Berendts, K., Bernstein, D.I., AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, year 3: what practices modify the risk of systemic reactions?. Ann Allergy Asthma Immunol 110 (2013), 274–278 278.e1.
7. 7 Bernstein, D.I., Epstein, T., Systemic reactions to subcutaneous allergen immunotherapy. Immunol Allergy Clin North Am 31 (2011), 241–249.
8. 8 Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 127 (2011), S1–S55.
9. 9 Epstein, T.G., Liss, G.M., Murphy-Berendts, K., Bernstein, D.I., Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2. Ann Allergy Asthma Immunol 107 (2011), 426–431.e1.
10. 10 Gupta, P., Gerrish, P.K., Silverman, B., Schneider, A., Current practices among allergists on writing self-injectable epinephrine prescriptions for immunotherapy patients. J Allergy Clin Immunol 129 (2012), 571–572 572.e1-2.
11. 11 Lieberman, P., Nicklas, R.A., Oppenheimer, J., Kemp, S.F., Lang, D.M., Bernstein, D.I., et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 126 (2010), 477–480.e1-42.
12. 12 Westermann-Clark, E., Fitzhugh, D.J., Lockey, R.F., Increasing cost of epinephrine autoinjectors. J Allergy Clin Immunol 130 (2012), 822–823.
13. 13 Rank, M.A., Bernstein, D.I., Improving the safety of immunotherapy. J Allergy Clin Immunol Pract 2 (2014), 131–135.
14. 14 Jutel, M., Agache, I., Bonini, S., Burks, A.W., Calderon, M., Canonica, W., et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol 136 (2015), 556–568.
15. 15 Lockey, R.F., Nicoara-Kasti, G.L., Theodoropoulos, D.S., Bukantz, S.C., Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 87 (2001), 47–55.
16. 16 Greenberg, M.A., Kaufman, C.R., Gonzalez, G.E., Trusewych, Z.P., Rosenblatt, C.D., Summers, R.J., Late systemic-allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol 82 (1988), 287–290.
17. 17 Bernstein, D.I., Epstein, T., Murphy-Berendts, K., Liss, G.M., Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol 104 (2010), 530–535.
18. 18 Epstein, T.G., Liss, G.M., Murphy-Berendts, K., Bernstein, D.I., AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract 2 (2014), 161–167.
19. 19 Clark, S., Wei, W., Rudders, S.A., Camargo, C.A. Jr., Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol 134 (2014), 1125–1130.
20. 20 Confino-Cohen, R., Goldberg, A., Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Ann Allergy Asthma Immunol 104 (2010), 73–78.